Tyrosine-kinase inhibitors (TKI) in first-line treatment of patients with non-small cell lung cancer (NSCLC) - real life data from Czech republik. In European respiratory Journal 2018
Tyrosine-kinase inhibitors (TKI) in first-line treatment of patients with non-small cell lung cancer (NSCLC) - real life data from Czech republik. In European respiratory Journal 2018
SKŘIČKOVÁ, Jana; Renata CHLOUPKOVÁ; Karel HEJDUK; Miloš PEŠEK; Vítězslav KOLEK; L KOUBKOVÁ; Jaromír ROUBEC; M ČERNOVSKÁ; František SALAJKA; J KKREJČÍ; L HAVEL; Marcela TOMÍŠKOVÁ; Monika ŠATÁNKOVÁ; Andrea BENEJOVÁ; I GRYGÁRKOVÁ; Michal HRNČIARIK; M ZEMANOVÁ; Dimka SIXTOVÁ; Zdeněk MERTA; P OPÁLKA a J KREJČÍ. Tyrosine-kinase inhibitors (TKI) in first-line treatment of patients with non-small cell lung cancer (NSCLC) - real life data from Czech republik. In European respiratory Journal 2018. In ERS international Congres 2018, European respiratory society Paris, France. 2018.
@proceedings{1498896, author = {Skřičková, Jana and Chloupková, Renata and Hejduk, Karel and Pešek, Miloš and Kolek, Vítězslav and Koubková, L and Roubec, Jaromír and Černovská, M and Salajka, František and Kkrejčí, J and Havel, L and Tomíšková, Marcela and Šatánková, Monika and Benejová, Andrea and Grygárková, I and Hrnčiarik, Michal and Zemanová, M and Sixtová, Dimka and Merta, Zdeněk and Opálka, P and Krejčí, J}, booktitle = {ERS international Congres 2018, European respiratory society Paris, France}, title = {Tyrosine-kinase inhibitors (TKI) in first-line treatment of patients with non-small cell lung cancer (NSCLC) - real life data from Czech republik. In European respiratory Journal 2018}, year = {2018} }
TY - CONF ID - 1498896 AU - Skřičková, Jana - Chloupková, Renata - Hejduk, Karel - Pešek, Miloš - Kolek, Vítězslav - Koubková, L - Roubec, Jaromír - Černovská, M - Salajka, František - Kkrejčí, J - Havel, L - Tomíšková, Marcela - Šatánková, Monika - Benejová, Andrea - Grygárková, I - Hrnčiarik, Michal - Zemanová, M - Sixtová, Dimka - Merta, Zdeněk - Opálka, P - Krejčí, J PY - 2018 TI - Tyrosine-kinase inhibitors (TKI) in first-line treatment of patients with non-small cell lung cancer (NSCLC) - real life data from Czech republik. In European respiratory Journal 2018 ER -
SKŘIČKOVÁ, Jana; Renata CHLOUPKOVÁ; Karel HEJDUK; Miloš PEŠEK; Vítězslav KOLEK; L KOUBKOVÁ; Jaromír ROUBEC; M ČERNOVSKÁ; František SALAJKA; J KKREJČÍ; L HAVEL; Marcela TOMÍŠKOVÁ; Monika ŠATÁNKOVÁ; Andrea BENEJOVÁ; I GRYGÁRKOVÁ; Michal HRNČIARIK; M ZEMANOVÁ; Dimka SIXTOVÁ; Zdeněk MERTA; P OPÁLKA a J KREJČÍ. Tyrosine-kinase inhibitors (TKI) in first-line treatment of patients with non-small cell lung cancer (NSCLC) - real life data from Czech republik. In European respiratory Journal 2018. In \textit{ERS international Congres 2018, European respiratory society Paris, France}. 2018.